Signal detail

News insight

Source-backed analysis, the reasoning behind the signal, and its market context.

Back to signals Ask the Agent

THRMBullishShares BuybackShort Term

High materiality9/10

Gentherm Reports 2026 Second Quarter Results and Announces a New Increased Stock Repurchase Authorization

StockNews.AIJul 23, 6:00 AM EDT1 source

Trading thesisImportance 9/10

Near-term upside bias for THRM on raised guidance, buyback, and Modine deal progress (0–3 months).

AI summary

What happened and why it matters

Gentherm posted Q2 revenue of $416.2M, up 11% YoY with ex-FX growth of 9.5% and Automotive up 9.8%. The company raised its 2026 guidance and authorized a $400M stock buyback. The Modine Performance Technologies merger remains on track for a late-2026 close, while the Innovative Medical Equipment ThermaZone acquisition broadens healthcare channel access.

Guidance hike plus $400M buyback support earnings multiple expansion.
Modine deal progression toward close by Q4 2026 provides optionality and potential synergies.
ThermaZone medical device acquisition broadens addressable market and cross-sell opportunities.
Automotive awards of $690M in the quarter underpin growth trajectory.

Sentiment rationale

Guidance raise, sizable buyback, and progress on a meaningful M&A transaction (Modine) are classic earnings/capital-allocation catalysts that can support multiple expansion and upside in THRM’s multiple, especially with improved liquidity and deleveraging potential.

Key facts

01
Gentherm Q2 revenue $416.2M, up 11% YoY; ex-FX growth 9.5%.
02
Automotive Climate and Comfort revenue +14.1% YoY; outpaced regional vehicle output by 14pp.
03
Board authorized new stock repurchase up to $400M; replaces prior program.
04
Raised full-year 2026 guidance: product revenues $1.55–$1.65B; Adj EBITDA $185–$200M; Adj FCF $85–$100M.
05
M&A updates: Modine Performance Technologies deal on track to close by early Q4 2026; Innovative Medical Equipment expands ThermaZone offering.

Corporate Developments

Category: Corporate Developments. The release blends earnings, capital allocation (buyback), and strategic M&A activity, highlighting catalysts that can drive near-term re-rating of THRM and potential long-term margin expansion through channel expansion and scale.